Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele
NY-ESO-1 elicits frequent antibody responses in cancer patients, accompanied by strong CD8(+) T cell responses against HLA-A2-restricted epitopes. To broaden the range of cancer patients who can be assessed for immunity to NY-ESO-1, a general method was devised to detect T cell reactivity independen...
Gespeichert in:
| Veröffentlicht in: | Proc Natl Acad Sci U S A |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
National Academy of Sciences
2000
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC27124/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11005863/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.97.20.10917 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
